Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

First evidence of glutathione metabolism in Leptospira interrogans.

Sasoni N, Ferrero DML, Guerrero SA, Iglesias AA, Arias DG.

Free Radic Biol Med. 2019 Aug 26;143:366-374. doi: 10.1016/j.freeradbiomed.2019.08.028. [Epub ahead of print]

PMID:
31465831
2.

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Crugnola M, Castagnetti F, Breccia M, Ferrero D, Trawinska MM, Abruzzese E, Annunziata M, Stagno F, Tiribelli M, Binotto G, Bonifacio M, Fava C, Iurlo A, Bucelli C, Mansueto G, Gozzini A, Falzetti F, Montefusco E, Crisà E, Gugliotta G, Russo S, Cedrone M, RussoRossi A, Pregno P, Isidori A, Mauro E, Atelda R, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Galimberti S, Orlandi E, Calistri E, Bocchia M, Cavazzini F, Rege Cambrin G, Orofino N, Luciano L, Sgherza N, Rosti G, Latagliata R, Capodanno I.

Ann Hematol. 2019 Oct;98(10):2329-2338. doi: 10.1007/s00277-019-03767-y. Epub 2019 Aug 7.

PMID:
31392461
3.

Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia.

Dragani M, Rege-Cambrin G, Ferrero D, Abruzzese E, Pregno P, Elena C, Cedrone M, Santoro M, Andreani G, Saglio G, Fava C.

Leuk Lymphoma. 2019 Jun 4:1-3. doi: 10.1080/10428194.2019.1622103. [Epub ahead of print] No abstract available.

PMID:
31161827
4.

FLAI induction regimen in elderly patients with acute myeloid leukemia.

Cerrano M, Candoni A, Crisà E, Dubbini MV, D'Ardia S, Zannier ME, Boccadoro M, Audisio E, Bruno B, Ferrero D.

Leuk Lymphoma. 2019 Jun 4:1-2. doi: 10.1080/10428194.2019.1620943. [Epub ahead of print] No abstract available.

PMID:
31159609
5.

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.

Baron F, Efficace F, Cannella L, Willemze R, Vignetti M, Muus P, Marie JP, Ferrero D, Fazi P, La Sala E, Bourhis JH, Fabbiano F, Bosi A, Sborgia M, Martinelli G, Wittnebel S, Trisolini S, Petti MC, Halkes CJM, van der Velden WJFM, de Witte T, Amadori S, Zittoun RA, Suciu S.

Haematologica. 2019 May 16. pii: haematol.2019.221333. doi: 10.3324/haematol.2019.221333. [Epub ahead of print]

6.

Supramolecular arrangement of the full-length Zika virus NS5.

Ferrero DS, Ruiz-Arroyo VM, Soler N, Usón I, Guarné A, Verdaguer N.

PLoS Pathog. 2019 Apr 5;15(4):e1007656. doi: 10.1371/journal.ppat.1007656. eCollection 2019 Apr.

7.

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML.

Bassan R, Intermesoli T, Masciulli A, Pavoni C, Boschini C, Gianfaldoni G, Marmont F, Cavattoni I, Mattei D, Terruzzi E, De Paoli L, Cattaneo C, Borlenghi E, Ciceri F, Bernardi M, Scattolin AM, Todisco E, Campiotti L, Corradini P, Cortelezzi A, Ferrero D, Zanghì P, Oldani E, Spinelli O, Audisio E, Cortelazzo S, Bosi A, Falini B, Pogliani EM, Rambaldi A.

Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

8.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.

Fava C, Rege-Cambrin G, Dogliotti I, Cerrano M, Berchialla P, Dragani M, Rosti G, Castagnetti F, Gugliotta G, Martino B, Gambacorti-Passerini C, Abruzzese E, Elena C, Pregno P, Gozzini A, Capodanno I, Bergamaschi M, Crugnola M, Bocchia M, Galimberti S, Rapezzi D, Iurlo A, Cattaneo D, Latagliata R, Breccia M, Cedrone M, Santoro M, Annunziata M, Levato L, Stagno F, Cavazzini F, Sgherza N, Giai V, Luciano L, Russo S, Musto P, Caocci G, Sorà F, Iuliano F, Lunghi F, Specchia G, Pane F, Ferrero D, Baccarani M, Saglio G.

Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.

9.

On the Roles of Wheat Endosperm ADP-Glucose Pyrophosphorylase Subunits.

Ferrero DML, Asencion Diez MD, Kuhn ML, Falaschetti CA, Piattoni CV, Iglesias AA, Ballicora MA.

Front Plant Sci. 2018 Oct 16;9:1498. doi: 10.3389/fpls.2018.01498. eCollection 2018.

10.

Sexual rejection via a vomeronasal receptor-triggered limbic circuit.

Osakada T, Ishii KK, Mori H, Eguchi R, Ferrero DM, Yoshihara Y, Liberles SD, Miyamichi K, Touhara K.

Nat Commun. 2018 Oct 26;9(1):4463. doi: 10.1038/s41467-018-07003-5.

11.

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.

Messa E, Gioia D, Masiera E, Castiglione A, Ceccarelli M, Salvi F, Danise P, Sanna A, Allione B, Balleari E, Poloni A, Cametti G, Ferrero D, Tassara R, Finelli C, Bonferroni M, Musto P, Saglio G, Levis A, Santini V.

Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3. No abstract available.

12.

Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients.

Brunello L, Passera R, Dellacasa CM, Giaccone L, Audisio E, Ferrero D, D'Ardia S, Allione B, Aydin S, Festuccia M, Lia G, Crisà E, Maffini E, Butera S, Busca A, Bruno B.

Ann Hematol. 2018 Nov;97(11):2205-2215. doi: 10.1007/s00277-018-3433-3. Epub 2018 Jul 9.

PMID:
29987350
13.

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.

Crisà E, Cilloni D, Elli EM, Martinelli V, Palumbo GA, Pugliese N, Beggiato E, Frairia C, Cerrano M, Lanzarone G, Marchetti M, Mezzabotta M, Boccadoro M, Ferrero D.

Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

PMID:
29984826
14.

Viral RNA-Dependent RNA Polymerases: A Structural Overview.

Ferrero D, Ferrer-Orta C, Verdaguer N.

Subcell Biochem. 2018;88:39-71. doi: 10.1007/978-981-10-8456-0_3. Review.

PMID:
29900492
15.

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.

Iurlo A, Galimberti S, Abruzzese E, Annunziata M, Bonifacio M, Latagliata R, Pregno P, Ferrero D, Sorà F, Orlandi EM, Fava C, Cattaneo D, Bucelli C, Binotto G, Pungolino E, Tiribelli M, Gozzini A, Gugliotta G, Castagnetti F, Stagno F, Rege-Cambrin G, Martino B, Luciano L, Breccia M, Sica S, Bocchia M, Pane F, Saglio G, Rosti G, Specchia G, Cortelezzi A, Baccarani M.

Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.

PMID:
28971265
16.

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Santini V, Allione B, Zini G, Gioia D, Lunghi M, Poloni A, Cilloni D, Sanna A, Masiera E, Ceccarelli M, Abdel-Wahab O, Terenzi A, Angelucci E, Finelli C, Onida F, Pelizzari A, Ferrero D, Saglio G, Figueroa M, Levis A.

Leukemia. 2018 Feb;32(2):413-418. doi: 10.1038/leu.2017.186. Epub 2017 Jun 13.

17.

Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study.

Messa E, Biale L, Castiglione A, Lunghi M, Bonferroni M, Salvi F, Allione B, Ferrero D, Calabrese C, De Gobbi M, Nicoli P, Gioia D, Levis A, Saglio G, Cilloni D.

Leuk Lymphoma. 2017 Nov;58(11):2752-2754. doi: 10.1080/10428194.2017.1312385. Epub 2017 May 9. No abstract available.

18.

Cytosolic Glyceraldehyde-3-Phosphate Dehydrogenase Is Phosphorylated during Seed Development.

Piattoni CV, Ferrero DML, Dellaferrera I, Vegetti A, Iglesias AÁ.

Front Plant Sci. 2017 Apr 11;8:522. doi: 10.3389/fpls.2017.00522. eCollection 2017.

19.

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

Park S, Hamel JF, Toma A, Kelaidi C, Thépot S, Campelo MD, Santini V, Sekeres MA, Balleari E, Kaivers J, Sapena R, Götze K, Müller-Thomas C, Beyne-Rauzy O, Stamatoullas A, Kotsianidis I, Komrokji R, Steensma DP, Fensterl J, Roboz GJ, Bernal T, Ramos F, Calabuig M, Guerci-Bresler A, Bordessoule D, Cony-Makhoul P, Cheze S, Wattel E, Rose C, Vey N, Gioia D, Ferrero D, Gaidano G, Cametti G, Pane F, Sanna A, Germing U, Sanz GF, Dreyfus F, Fenaux P.

J Clin Oncol. 2017 May 10;35(14):1591-1597. doi: 10.1200/JCO.2016.71.3271. Epub 2017 Mar 28.

PMID:
28350519
20.

Can pegylated interferon improve the outcome of polycythemia vera patients?

Crisà E, Cerrano M, Beggiato E, Benevolo G, Lanzarone G, Manzini PM, Borchiellini A, Riera L, Boccadoro M, Ferrero D.

J Hematol Oncol. 2017 Jan 13;10(1):15. doi: 10.1186/s13045-017-0395-1.

21.

Poster 384 Culture-Negative Osteomyelitis of the Femoral Diaphysis Initially Presenting as Lumbar Radiculopathy in an Otherwise Healthy Individual: A Case Report.

Strong NA, Kruppenbacher MC, Ferrero DG.

PM R. 2016 Sep;8(9S):S286. doi: 10.1016/j.pmrj.2016.07.311. Epub 2016 Sep 24. No abstract available.

PMID:
27673136
22.

Cross-Country Individual Participant Analysis of 4.1 Million Singleton Births in 5 Countries with Very High Human Development Index Confirms Known Associations but Provides No Biologic Explanation for 2/3 of All Preterm Births.

Ferrero DM, Larson J, Jacobsson B, Di Renzo GC, Norman JE, Martin JN Jr, D'Alton M, Castelazo E, Howson CP, Sengpiel V, Bottai M, Mayo JA, Shaw GM, Verdenik I, Tul N, Velebil P, Cairns-Smith S, Rushwan H, Arulkumaran S, Howse JL, Simpson JL.

PLoS One. 2016 Sep 13;11(9):e0162506. doi: 10.1371/journal.pone.0162506. eCollection 2016. Review.

23.

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.

Iurlo A, Nobili A, Latagliata R, Bucelli C, Castagnetti F, Breccia M, Abruzzese E, Cattaneo D, Fava C, Ferrero D, Gozzini A, Bonifacio M, Tiribelli M, Pregno P, Stagno F, Vigneri P, Annunziata M, Cavazzini F, Binotto G, Mansueto G, Russo S, Falzetti F, Montefusco E, Gugliotta G, Storti S, D'Addosio AM, Scaffidi L, Cortesi L, Cedrone M, Rossi AR, Avanzini P, Mauro E, Spadea A, Celesti F, Giglio G, Isidori A, Crugnola M, Calistri E, Sorà F, Rege-Cambrin G, Sica S, Luciano L, Galimberti S, Orlandi EM, Bocchia M, Tettamanti M, Alimena G, Saglio G, Rosti G, Mannucci PM, Cortelezzi A.

Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.

24.

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.

Maffini E, Giaccone L, Festuccia M, Brunello L, Buondonno I, Ferrero D, Boccadoro M, Dellacasa C, Busca A, Novero D, Bruno B.

J Hematol Oncol. 2016 Aug 8;9(1):67. doi: 10.1186/s13045-016-0298-6.

25.

Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.

Cerrano M, Crisà E, Gottardi E, Aguzzi C, Boccadoro M, Ferrero D.

Am J Hematol. 2016 Sep;91(9):E353. doi: 10.1002/ajh.24422. Epub 2016 Jun 20. No abstract available.

26.

Anemia in the Elderly: not Always what it Seems.

Cerrano M, Crisà E, Giai V, Boccadoro M, Ferrero D.

Mediterr J Hematol Infect Dis. 2016 Feb 25;8(1):e2016017. doi: 10.4084/MJHID.2016.017. eCollection 2016.

27.

How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience.

Ferrero D, Cerrano M, Crisà E, Aguzzi C, Giai V, Boccadoro M.

Br J Haematol. 2017 Feb;176(4):669-671. doi: 10.1111/bjh.13983. Epub 2016 Feb 23. No abstract available.

PMID:
26914729
28.

Self-collected glans/meatal 'dry' swab specimen and NAAT technology detects Chlamydia trachomatis and Neisseria gonorrhoeae - implications for public policy changes.

Ferrero DV, Meyers HN, Ferrero GM, Schultz DE.

Int J STD AIDS. 2017 Sep;28(10):985-990. doi: 10.1177/0956462416684693. Epub 2016 Dec 20.

PMID:
28632470
29.

The Structure of the RNA-Dependent RNA Polymerase of a Permutotetravirus Suggests a Link between Primer-Dependent and Primer-Independent Polymerases.

Ferrero DS, Buxaderas M, Rodríguez JF, Verdaguer N.

PLoS Pathog. 2015 Dec 1;11(12):e1005265. doi: 10.1371/journal.ppat.1005265. eCollection 2015 Dec.

30.

Infectious Bursal Disease Virus VP3 Upregulates VP1-Mediated RNA-Dependent RNA Replication.

Ferrero D, Garriga D, Navarro A, Rodríguez JF, Verdaguer N.

J Virol. 2015 Nov;89(21):11165-8. doi: 10.1128/JVI.00218-15. Epub 2015 Aug 26.

31.

RNA-Dependent RNA Polymerases of Picornaviruses: From the Structure to Regulatory Mechanisms.

Ferrer-Orta C, Ferrero D, Verdaguer N.

Viruses. 2015 Aug 6;7(8):4438-60. doi: 10.3390/v7082829. Review.

32.

Viruses and viral proteins.

Verdaguer N, Ferrero D, Murthy MR.

IUCrJ. 2014 Oct 14;1(Pt 6):492-504. doi: 10.1107/S205225251402003X. eCollection 2014 Nov 1. Review.

33.

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival.

Breccia M, Luciano L, Latagliata R, Castagnetti F, Ferrero D, Cavazzini F, Trawinska MM, Annunziata M, Stagno F, Tiribelli M, Binotto G, Crisà E, Musto P, Gozzini A, Cavalli L, Montefusco E, Iurlo A, Russo S, Cedrone M, Rossi AR, Pregno P, Endri M, Spadea A, Molica M, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Cambrin GR, Isidori A, Sica S, Abruzzese E, Speccha G, Rosti G, Alimena G.

Leuk Res. 2014 Oct;38(10):1173-6. doi: 10.1016/j.leukres.2014.06.020. Epub 2014 Jul 7.

PMID:
25047978
34.

Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.

Ferrero D, Crisà E, Marmont F, Audisio E, Frairia C, Giai V, Gatti T, Festuccia M, Bruno B, Riera L, Passera R, Boccadoro M.

Ann Hematol. 2014 Aug;93(8):1391-400. doi: 10.1007/s00277-014-2047-7. Epub 2014 Apr 6.

PMID:
24705888
35.

High-affinity olfactory receptor for the death-associated odor cadaverine.

Hussain A, Saraiva LR, Ferrero DM, Ahuja G, Krishna VS, Liberles SD, Korsching SI.

Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19579-84. doi: 10.1073/pnas.1318596110. Epub 2013 Nov 11.

36.

A juvenile mouse pheromone inhibits sexual behaviour through the vomeronasal system.

Ferrero DM, Moeller LM, Osakada T, Horio N, Li Q, Roy DS, Cichy A, Spehr M, Touhara K, Liberles SD.

Nature. 2013 Oct 17;502(7471):368-71. doi: 10.1038/nature12579. Epub 2013 Oct 2.

37.

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Santini V, Schemenau J, Levis A, Balleari E, Sapena R, Adès L, Guerci A, Beyne-Rauzy O, Gourin MP, Cheze S, Stamatoullas A, Sanna A, Gioia D, Cametti G, Ferrero D, Raffoux E, Rose C, Poloni A, Prebet T, Legros L, Natarajan-Amé S, Fenaux P, Germing U, Dreyfus F, Park S.

Blood. 2013 Sep 26;122(13):2286-8. doi: 10.1182/blood-2013-07-512442. No abstract available.

PMID:
24072851
38.

Animal behavior: shifting neural circuits with sex hormones.

Ferrero DM, Liberles SD.

Curr Biol. 2013 Jul 22;23(14):R621-3. doi: 10.1016/j.cub.2013.06.007.

39.

Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: a retrospective study on 91 unselected patients.

Cerrano M, Crisà E, Pregno P, Aguzzi C, Riccomagno P, Boccadoro M, Ferrero D.

Am J Hematol. 2013 Oct;88(10):838-42. doi: 10.1002/ajh.23501. Epub 2013 Jul 23.

40.

Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.

Latagliata R, Ferrero D, Iurlo A, Cavazzini F, Castagnetti F, Abruzzese E, Fava C, Breccia M, Annunziata M, Stagno F, Tiribelli M, Binotto G, Mansueto G, Gozzini A, Russo S, Cavalli L, Montefusco E, Gugliotta G, Cedrone M, Russo Rossi A, Avanzini P, Pregno P, Mauro E, Spadea A, Celesti F, Giglio G, Isidori A, Crugnola M, Calistri E, Sorà F, Storti S, D'Addosio A, Rege-Cambrin G, Luciano L, Alimena G.

Drugs Aging. 2013 Aug;30(8):629-37. doi: 10.1007/s40266-013-0088-6.

PMID:
23681399
41.

Tecnology innovation related to comfort on commercial vehicles.

Martini M, Ferrero D.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3):321-7.

PMID:
23213810
42.

Synchronous evolution of an odor biosynthesis pathway and behavioral response.

Li Q, Korzan WJ, Ferrero DM, Chang RB, Roy DS, Buchi M, Lemon JK, Kaur AW, Stowers L, Fendt M, Liberles SD.

Curr Biol. 2013 Jan 7;23(1):11-20. doi: 10.1016/j.cub.2012.10.047. Epub 2012 Nov 21.

43.

The VP3 factor from viruses of Birnaviridae family suppresses RNA silencing by binding both long and small RNA duplexes.

Valli A, Busnadiego I, Maliogka V, Ferrero D, Castón JR, Rodríguez JF, García JA.

PLoS One. 2012;7(9):e45957. doi: 10.1371/journal.pone.0045957. Epub 2012 Sep 25.

44.

Purification, crystallization and preliminary X-ray diffraction analysis of the RNA-dependent RNA polymerase from Thosea asigna virus.

Ferrero D, Buxaderas M, Rodriguez JF, Verdaguer N.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1263-6. doi: 10.1107/S1744309112037529. Epub 2012 Sep 29.

45.

Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.

Latagliata R, Breccia M, Fava C, Stagno F, Tiribelli M, Luciano L, Gozzini A, Gugliotta G, Annunziata M, Cavazzini F, Ferrero D, Musto P, Capodanno I, Iurlo A, Visani G, Crugnola M, Calistri E, Castagnetti F, Vigneri P, Alimena G.

Hematol Oncol. 2013 Jun;31(2):103-9. doi: 10.1002/hon.2020. Epub 2012 Jul 19. Erratum in: Hematol Oncol. 2013 Spe;31(3):169.

PMID:
22815278
46.

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.

Lobetti-Bodoni C, Ferrero D, Genuardi E, Passera R, Bernocco E, Sia D, Grignani G, Crisà E, Monitillo L, Rocci A, Drandi D, Giai V, Zanni M, Boi M, Isaia G, Barbero D, Lunghi M, Abruzzese E, Radaelli F, Pini M, Pregno P, Carlo-Stella C, Gaidano G, Boccadoro M, Ladetto M.

Mech Ageing Dev. 2012 Jul;133(7):479-88. doi: 10.1016/j.mad.2012.05.007. Epub 2012 Jun 9.

PMID:
22687638
47.

Long-term follow-up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survival.

Crisà E, Foli C, Passera R, Darbesio A, Garvey KB, Boccadoro M, Ferrero D.

Br J Haematol. 2012 Jul;158(1):99-107. doi: 10.1111/j.1365-2141.2012.09125.x. Epub 2012 May 10.

PMID:
22571649
48.

Agonists for 13 trace amine-associated receptors provide insight into the molecular basis of odor selectivity.

Ferrero DM, Wacker D, Roque MA, Baldwin MW, Stevens RC, Liberles SD.

ACS Chem Biol. 2012 Jul 20;7(7):1184-9. doi: 10.1021/cb300111e. Epub 2012 May 7.

49.

The C-terminal extension of chloroplast 2-Cys peroxiredoxin is critical for interaction with ATP.

Ferrero D, Aran M, Rimmaudo L, Wolosiuk RA.

Biochemistry. 2012 Mar 20;51(11):2169-71. doi: 10.1021/bi201843b. Epub 2012 Mar 6.

PMID:
22385109
50.

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program.

Maurillo L, Venditti A, Spagnoli A, Gaidano G, Ferrero D, Oliva E, Lunghi M, D'Arco AM, Levis A, Pastore D, Di Renzo N, Santagostino A, Pavone V, Buccisano F, Musto P.

Cancer. 2012 Feb 15;118(4):1014-22. doi: 10.1002/cncr.26354. Epub 2011 Jul 14.

Supplemental Content

Loading ...
Support Center